ID   ODB2_HUMAN              Reviewed;         482 AA.
AC   P11182; B2R811; Q5VVL8;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 3.
DT   10-MAY-2017, entry version 212.
DE   RecName: Full=Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial;
DE            EC=2.3.1.168;
DE   AltName: Full=52 kDa mitochondrial autoantigen of primary biliary cirrhosis {ECO:0000303|PubMed:2908870};
DE   AltName: Full=Branched chain 2-oxo-acid dehydrogenase complex component E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};
DE            Short=BCOADC-E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};
DE   AltName: Full=Branched-chain alpha-keto acid dehydrogenase complex component E2;
DE            Short=BCKAD-E2;
DE            Short=BCKADE2;
DE   AltName: Full=Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex;
DE   AltName: Full=Dihydrolipoamide branched chain transacylase;
DE   AltName: Full=Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase;
DE   Flags: Precursor;
GN   Name=DBT; Synonyms=BCATE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=1420314; DOI=10.1016/0167-4781(92)90169-Z;
RA   Lau K.S., Chuang J.L., Herring W.J., Danner D.J., Cox R.P.,
RA   Chuang D.T.;
RT   "The complete cDNA sequence for dihydrolipoyl transacylase (E2) of
RT   human branched-chain alpha-keto acid dehydrogenase complex.";
RL   Biochim. Biophys. Acta 1132:319-321(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3245861;
RA   Hummel K.B., Litwer S., Bradford A.P., Aitken A., Danner D.J.,
RA   Yeaman S.J.;
RT   "Nucleotide sequence of a cDNA for branched chain acyltransferase with
RT   analysis of the deduced protein structure.";
RL   J. Biol. Chem. 263:6165-6168(1988).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=2708389;
RA   Danner D.J., Litwer S., Herring W.J., Pruckler J.;
RT   "Construction and nucleotide sequence of a cDNA encoding the full-
RT   length preprotein for human branched chain acyltransferase.";
RL   J. Biol. Chem. 264:7742-7746(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2742576; DOI=10.1016/0006-291X(89)91347-8;
RA   Nobukuni Y., Mitsubuchi H., Endo F., Matsuda I.;
RT   "Complete primary structure of the transacylase (E2b) subunit of the
RT   human branched chain alpha-keto acid dehydrogenase complex.";
RL   Biochem. Biophys. Res. Commun. 161:1035-1041(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-384.
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-313.
RX   PubMed=2837277; DOI=10.1021/bi00406a025;
RA   Lau K.S., Griffin T.A., Hu C.-W.C., Chuang D.T.;
RT   "Conservation of primary structure in the lipoyl-bearing and
RT   dihydrolipoyl dehydrogenase binding domains of mammalian branched-
RT   chain alpha-keto acid dehydrogenase complex: molecular cloning of
RT   human and bovine transacylase (E2) cDNAs.";
RL   Biochemistry 27:1972-1981(1988).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6.
RX   PubMed=1429740;
RA   Lau K.S., Herring W.J., Chuang J.L., McKean M., Danner D.J., Cox R.P.,
RA   Chuang D.T.;
RT   "Structure of the gene encoding dihydrolipoyl transacylase (E2)
RT   component of human branched chain alpha-keto acid dehydrogenase
RT   complex and characterization of an E2 pseudogene.";
RL   J. Biol. Chem. 267:24090-24096(1992).
RN   [12]
RP   PROTEIN SEQUENCE OF 47-81.
RX   PubMed=7918575; DOI=10.1016/0304-4165(94)90161-9;
RA   Wynn R.M., Kochi H., Cox R.P., Chuang D.T.;
RT   "Differential processing of human and rat E1 alpha precursors of the
RT   branched-chain alpha-keto acid dehydrogenase complex caused by an N-
RT   terminal proline in the rat sequence.";
RL   Biochim. Biophys. Acta 1201:125-128(1994).
RN   [13]
RP   INVOLVEMENT IN PBC.
RX   PubMed=2908870; DOI=10.1002/hep.1840090110;
RA   Surh C.D., Danner D.J., Ahmed A., Coppel R.L., Mackay I.R.,
RA   Dickson E.R., Gershwin M.E.;
RT   "Reactivity of primary biliary cirrhosis sera with a human fetal liver
RT   cDNA clone of branched-chain alpha-keto acid dehydrogenase
RT   dihydrolipoamide acyltransferase, the 52 kD mitochondrial
RT   autoantigen.";
RL   Hepatology 9:63-68(1989).
RN   [14]
RP   INVOLVEMENT IN PBC.
RX   PubMed=7543435; DOI=10.1016/0270-9139(95)90572-3;
RA   Leung P.S., Chuang D.T., Wynn R.M., Cha S., Danner D.J., Ansari A.,
RA   Coppel R.L., Gershwin M.E.;
RT   "Autoantibodies to BCOADC-E2 in patients with primary biliary
RT   cirrhosis recognize a conformational epitope.";
RL   Hepatology 22:505-513(1995).
RN   [15]
RP   INVOLVEMENT IN PBC.
RX   PubMed=9141421; DOI=10.1002/hep.510250506;
RA   Nishio A., Van de Water J., Leung P.S., Joplin R., Neuberger J.M.,
RA   Lake J., Bjoerkland A., Toetterman T.H., Peters M., Worman H.J.,
RA   Ansari A.A., Coppel R.L., Gershwin M.E.;
RT   "Comparative studies of antimitochondrial autoantibodies in sera and
RT   bile in primary biliary cirrhosis.";
RL   Hepatology 25:1085-1089(1997).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-295, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-220, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   STRUCTURE BY NMR OF 62-145.
RX   PubMed=11839747; DOI=10.1074/jbc.M110952200;
RA   Chang C.-F., Chou H.-T., Chuang J.L., Chuang D.T., Huang T.-H.;
RT   "Solution structure and dynamics of the lipoic acid-bearing domain of
RT   human mitochondrial branched-chain alpha-keto acid dehydrogenase
RT   complex.";
RL   J. Biol. Chem. 277:15865-15873(2002).
RN   [21]
RP   STRUCTURE BY NMR OF 163-220.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the E3-binding domain of dihydrolipoamide
RT   branched chain transacylase.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [22]
RP   VARIANT MSUD2 CYS-276.
RX   PubMed=1847055; DOI=10.1016/0006-291X(91)91489-Y;
RA   Fisher C.W., Lau K.S., Fisher C.R., Wynn R.M., Cox R.P., Chuang D.T.;
RT   "A 17-bp insertion and a Phe215-->Cys missense mutation in the
RT   dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple
RT   syrup urine disease patient WG-34.";
RL   Biochem. Biophys. Res. Commun. 174:804-809(1991).
RN   [23]
RP   VARIANTS MSUD2 MET-98 AND SER-384.
RX   PubMed=9621512; DOI=10.1007/s100380050047;
RA   Tsuruta M., Mitsubuchi H., Mardy S., Miura Y., Hayashida Y.,
RA   Kinugasa A., Ishitsu T., Matsuda I., Indo Y.;
RT   "Molecular basis of intermittent maple syrup urine disease: novel
RT   mutations in the E2 gene of the branched-chain alpha-keto acid
RT   dehydrogenase complex.";
RL   J. Hum. Genet. 43:91-100(1998).
CC   -!- FUNCTION: The branched-chain alpha-keto dehydrogenase complex
CC       catalyzes the overall conversion of alpha-keto acids to acyl-CoA
CC       and CO(2). It contains multiple copies of three enzymatic
CC       components: branched-chain alpha-keto acid decarboxylase (E1),
CC       lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3).
CC       Within this complex, the catalytic function of this enzyme is to
CC       accept, and to transfer to coenzyme A, acyl groups that are
CC       generated by the branched-chain alpha-keto acid decarboxylase
CC       component.
CC   -!- CATALYTIC ACTIVITY: 2-methylpropanoyl-CoA + enzyme N(6)-
CC       (dihydrolipoyl)lysine = CoA + enzyme N(6)-(S-(2-
CC       methylpropanoyl)dihydrolipoyl)lysine.
CC   -!- COFACTOR:
CC       Name=(R)-lipoate; Xref=ChEBI:CHEBI:83088;
CC       Note=Binds 1 lipoyl cofactor covalently.;
CC   -!- SUBUNIT: Forms a 24-polypeptide structural core with octahedral
CC       symmetry.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- DISEASE: Note=Patients with primary biliary cirrhosis (PBC) show
CC       autoantibodies against the E2 component of branched-chain alpha-
CC       keto acid dehydrogenase complex. PBC is a chronic, progressive
CC       cholestatic liver disease characterized by the presence of
CC       antimitochondrial autoantibodies in patients serum. It manifests
CC       with inflammatory obliteration of intra-hepatic bile duct, leading
CC       to liver cell damage and cirrhosis. {ECO:0000269|PubMed:2908870,
CC       ECO:0000269|PubMed:7543435, ECO:0000269|PubMed:9141421}.
CC   -!- DISEASE: Maple syrup urine disease 2 (MSUD2) [MIM:248600]: A
CC       metabolic disorder due to an enzyme defect in the catabolic
CC       pathway of the branched-chain amino acids leucine, isoleucine, and
CC       valine. Accumulation of these 3 amino acids and their
CC       corresponding keto acids leads to encephalopathy and progressive
CC       neurodegeneration. Clinical features include mental and physical
CC       retardation, feeding problems, and a maple syrup odor to the
CC       urine. The keto acids of the branched-chain amino acids are
CC       present in the urine. If untreated, maple syrup urine disease can
CC       lead to seizures, coma, and death. The disease is often classified
CC       by its pattern of signs and symptoms. The most common and severe
CC       form of the disease is the classic type, which becomes apparent
CC       soon after birth. Variant forms of the disorder become apparent
CC       later in infancy or childhood and are typically milder, but they
CC       still involve developmental delay and other medical problems if
CC       not treated. {ECO:0000269|PubMed:1847055,
CC       ECO:0000269|PubMed:9621512}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 2-oxoacid dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA35589.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAA64512.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66785; CAA47285.1; -; mRNA.
DR   EMBL; J03208; AAA35589.1; ALT_INIT; mRNA.
DR   EMBL; M27093; AAA64512.1; ALT_INIT; mRNA.
DR   EMBL; BT007372; AAP36036.1; -; mRNA.
DR   EMBL; AL445928; CAH72257.1; -; Genomic_DNA.
DR   EMBL; AK313191; BAG36008.1; -; mRNA.
DR   EMBL; CH471097; EAW72963.1; -; Genomic_DNA.
DR   EMBL; BC016675; AAH16675.1; -; mRNA.
DR   EMBL; M19301; AAA59200.1; ALT_SEQ; mRNA.
DR   EMBL; X68104; CAA48225.1; -; Genomic_DNA.
DR   CCDS; CCDS767.1; -.
DR   PIR; A32422; A32422.
DR   RefSeq; NP_001909.3; NM_001918.3.
DR   UniGene; Hs.709187; -.
DR   PDB; 1K8M; NMR; -; A=62-145.
DR   PDB; 1K8O; NMR; -; A=62-145.
DR   PDB; 1ZWV; NMR; -; A=165-213.
DR   PDB; 2COO; NMR; -; A=163-220.
DR   PDB; 3RNM; X-ray; 2.40 A; E/F=165-213.
DR   PDBsum; 1K8M; -.
DR   PDBsum; 1K8O; -.
DR   PDBsum; 1ZWV; -.
DR   PDBsum; 2COO; -.
DR   PDBsum; 3RNM; -.
DR   ProteinModelPortal; P11182; -.
DR   SMR; P11182; -.
DR   BioGrid; 107997; 46.
DR   IntAct; P11182; 22.
DR   MINT; MINT-1161634; -.
DR   STRING; 9606.ENSP00000359151; -.
DR   iPTMnet; P11182; -.
DR   PhosphoSitePlus; P11182; -.
DR   SwissPalm; P11182; -.
DR   BioMuta; DBT; -.
DR   DMDM; 400668; -.
DR   EPD; P11182; -.
DR   MaxQB; P11182; -.
DR   PaxDb; P11182; -.
DR   PeptideAtlas; P11182; -.
DR   PRIDE; P11182; -.
DR   DNASU; 1629; -.
DR   Ensembl; ENST00000370132; ENSP00000359151; ENSG00000137992.
DR   GeneID; 1629; -.
DR   KEGG; hsa:1629; -.
DR   UCSC; uc001dta.4; human.
DR   CTD; 1629; -.
DR   DisGeNET; 1629; -.
DR   GeneCards; DBT; -.
DR   GeneReviews; DBT; -.
DR   H-InvDB; HIX0000815; -.
DR   HGNC; HGNC:2698; DBT.
DR   HPA; HPA026481; -.
DR   HPA; HPA026485; -.
DR   HPA; HPA026533; -.
DR   MalaCards; DBT; -.
DR   MIM; 248600; phenotype.
DR   MIM; 248610; gene.
DR   neXtProt; NX_P11182; -.
DR   Orphanet; 268145; Classic maple syrup urine disease.
DR   Orphanet; 268162; Intermediate maple syrup urine disease.
DR   Orphanet; 268173; Intermittent maple syrup urine disease.
DR   Orphanet; 268184; Thiamine-responsive maple syrup urine disease.
DR   PharmGKB; PA27167; -.
DR   eggNOG; KOG0558; Eukaryota.
DR   eggNOG; COG0508; LUCA.
DR   HOGENOM; HOG000281564; -.
DR   HOVERGEN; HBG104085; -.
DR   InParanoid; P11182; -.
DR   KO; K09699; -.
DR   OrthoDB; EOG091G0FJ3; -.
DR   PhylomeDB; P11182; -.
DR   TreeFam; TF314182; -.
DR   BioCyc; MetaCyc:MONOMER-12007; -.
DR   BRENDA; 2.3.1.168; 2681.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   ChiTaRS; DBT; human.
DR   EvolutionaryTrace; P11182; -.
DR   GeneWiki; DBT_(gene); -.
DR   GenomeRNAi; 1629; -.
DR   PRO; PR:P11182; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000137992; -.
DR   CleanEx; HS_DBT; -.
DR   ExpressionAtlas; P11182; baseline and differential.
DR   Genevisible; P11182; HS.
DR   GO; GO:0005947; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; TAS:ProtInc.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043754; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   Gene3D; 4.10.320.10; -; 1.
DR   InterPro; IPR003016; 2-oxoA_DH_lipoyl-BS.
DR   InterPro; IPR001078; 2-oxoacid_DH_actylTfrase.
DR   InterPro; IPR015761; BCKDC_E2.
DR   InterPro; IPR000089; Biotin_lipoyl.
DR   InterPro; IPR004167; E3-bd.
DR   InterPro; IPR011053; Single_hybrid_motif.
DR   PANTHER; PTHR43178:SF3; PTHR43178:SF3; 1.
DR   Pfam; PF00198; 2-oxoacid_dh; 1.
DR   Pfam; PF00364; Biotin_lipoyl; 1.
DR   Pfam; PF02817; E3_binding; 1.
DR   SUPFAM; SSF47005; SSF47005; 1.
DR   SUPFAM; SSF51230; SSF51230; 1.
DR   PROSITE; PS50968; BIOTINYL_LIPOYL; 1.
DR   PROSITE; PS00189; LIPOYL; 1.
DR   PROSITE; PS51826; PSBD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Lipoyl;
KW   Maple syrup urine disease; Mitochondrion; Phosphoprotein;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     61       Mitochondrion. {ECO:0000255}.
FT   CHAIN        62    482       Lipoamide acyltransferase component of
FT                                branched-chain alpha-keto acid
FT                                dehydrogenase complex, mitochondrial.
FT                                /FTId=PRO_0000020489.
FT   DOMAIN       64    139       Lipoyl-binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066}.
FT   DOMAIN      172    209       Peripheral subunit-binding (PSBD).
FT                                {ECO:0000255|PROSITE-ProRule:PRU01170}.
FT   ACT_SITE    452    452       {ECO:0000255}.
FT   ACT_SITE    456    456       {ECO:0000255}.
FT   MOD_RES     105    105       N6-lipoyllysine. {ECO:0000250,
FT                                ECO:0000255|PROSITE-ProRule:PRU01066}.
FT   MOD_RES     133    133       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     196    196       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     196    196       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     202    202       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     220    220       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     243    243       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     250    250       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     261    261       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     289    289       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     289    289       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     295    295       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     304    304       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     435    435       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     440    440       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   MOD_RES     440    440       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P53395}.
FT   VARIANT      98     98       I -> M (in MSUD2).
FT                                {ECO:0000269|PubMed:9621512}.
FT                                /FTId=VAR_015099.
FT   VARIANT     276    276       F -> C (in MSUD2).
FT                                {ECO:0000269|PubMed:1847055}.
FT                                /FTId=VAR_004978.
FT   VARIANT     384    384       G -> S (in MSUD2; dbSNP:rs12021720).
FT                                {ECO:0000269|PubMed:16710414,
FT                                ECO:0000269|PubMed:9621512}.
FT                                /FTId=VAR_015100.
FT   CONFLICT    321    321       Q -> P (in Ref. 4; AAA64512).
FT                                {ECO:0000305}.
FT   CONFLICT    354    354       L -> V (in Ref. 4; AAA64512).
FT                                {ECO:0000305}.
FT   STRAND       65     68       {ECO:0000244|PDB:1K8M}.
FT   STRAND       79     84       {ECO:0000244|PDB:1K8M}.
FT   STRAND       94     96       {ECO:0000244|PDB:1K8M}.
FT   STRAND       99    102       {ECO:0000244|PDB:1K8M}.
FT   STRAND      107    109       {ECO:0000244|PDB:1K8M}.
FT   STRAND      116    121       {ECO:0000244|PDB:1K8M}.
FT   STRAND      125    129       {ECO:0000244|PDB:1K8O}.
FT   STRAND      133    139       {ECO:0000244|PDB:1K8M}.
FT   HELIX       175    183       {ECO:0000244|PDB:3RNM}.
FT   HELIX       188    190       {ECO:0000244|PDB:3RNM}.
FT   HELIX       196    198       {ECO:0000244|PDB:3RNM}.
FT   HELIX       202    213       {ECO:0000244|PDB:3RNM}.
SQ   SEQUENCE   482 AA;  53487 MW;  A7CA728C8F33D126 CRC64;
     MAAVRMLRTW SRNAGKLICV RYFQTCGNVH VLKPNYVCFF GYPSFKYSHP HHFLKTTAAL
     RGQVVQFKLS DIGEGIREVT VKEWYVKEGD TVSQFDSICE VQSDKASVTI TSRYDGVIKK
     LYYNLDDIAY VGKPLVDIET EALKDSEEDV VETPAVSHDE HTHQEIKGRK TLATPAVRRL
     AMENNIKLSE VVGSGKDGRI LKEDILNYLE KQTGAILPPS PKVEIMPPPP KPKDMTVPIL
     VSKPPVFTGK DKTEPIKGFQ KAMVKTMSAA LKIPHFGYCD EIDLTELVKL REELKPIAFA
     RGIKLSFMPF FLKAASLGLL QFPILNASVD ENCQNITYKA SHNIGIAMDT EQGLIVPNVK
     NVQICSIFDI ATELNRLQKL GSVGQLSTTD LTGGTFTLSN IGSIGGTFAK PVIMPPEVAI
     GALGSIKAIP RFNQKGEVYK AQIMNVSWSA DHRVIDGATM SRFSNLWKSY LENPAFMLLD
     LK
//
